Mitrecin A Polypeptide Broad-Spectrum Antimicrobial Activity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current bacteriocins have limited broad-spectrum activity and resistance issues, such as nisin-resistant L. monocytogenes strains, necessitating a safe and effective antimicrobial agent for food preservation and pathogen control.

Innovation Solution

Development of an isolated polypeptide, Mitrecin A, with a specific amino acid sequence that effectively kills or inhibits a wide range of bacteria, including Gram-positive and Gram-negative species, by targeting cell membranes without cross-resistance with antibiotics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If nisin is used as an antimicrobial agent, then antimicrobial activity is achieved, but resistance develops (nisin-resistant L. monocytogenes strains)

Engineering Contradiction:
Improveantimicrobial activityVSAvoidbacterial resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the amino acid sequence parameters of the bacteriocin by incorporating specific conserved regions (amino acids 54-73, 81-90, and 106-121) to enhance antimicrobial activity against L. monocytogenes while reducing resistance development. The sequence variations in these conserved regions create structural differences that prevent resistance mechanisms.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite antimicrobial agent by combining multiple functional regions within a single polypeptide structure. The polypeptide integrates signal peptide sequences, conserved catalytic domains, and variable regions that work synergistically to achieve broad-spectrum activity including resistance to nisin-resistant strains.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If bacteriocins with narrow inhibitory spectrum are used, then specificity is maintained, but broad-spectrum coverage is limited

Engineering Contradiction:
Improvebroad-spectrum activityVSAvoidlack of specificity
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent designs a multi-functional bacteriocin polypeptide that performs multiple functions: it exhibits activity against both Gram-positive and Gram-negative bacteria, possesses proteolytic enzymatic activity, and maintains structural stability. The conserved regions provide catalytic functionality while variable regions enable spectrum broadening without complete loss of specificity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Mitrecin A provides broad-spectrum bactericidal activity against various bacterial species, extending food shelf life, reducing spoilage, and preventing disease, while being safe for human consumption and the environment.

Implementation Method 1

bacteriocins typically act on the cell membrane

Methodology Applied
Scientific EffectCell membrane disruption:

Data Source

PatentUS11649267B2Mitrecin A polypeptide with antimicrobial activity
Publication Date: 2023.05.16 THE MITRE CORPORATION
  • US11649267B2 patent drawing
  • US11649267B2 patent drawing
  • US11649267B2 patent drawing

AI summary

The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.